EUVIMEDEUVIMED entdecken
Crossref

PROSPECTIVE POSTMORTEM ASSESSMENT OF THE INCIDENCE OF MAMMARY NEOPLASIA IN CHIMPANZEES (PAN TROGLODYTES)

Jessica N Lovstad, Kathryn Gamble, Megan Sullivan, Michael Akroush, Karen A Terio

Journal of Zoo and Wildlife Medicine · 04.10.2023 · 54 (3) · 428-434

DOI: 10.1638/2022-0146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Zoo and Wildlife Medicine, erschienen am 04.10.2023. Verfasst von Jessica N Lovstad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lincoln Park Zoo, Chicago, IL 60614 USA, jlovstad@rwpzoo.org. Hauptthemen laut MEDLINE: Pan troglodytes, Hominidae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

When evaluating the last 25 yr of morbidity and mortality from adult chimpanzees managed within the Association of Zoo and Aquarium Chimpanzee Species Survival Plan® for North American zoos, only two female chimpanzees were diagnosed with mammary neoplasia: one incidentally antemortem and one with a terminal metastatic neoplasia. When comparing this observation of prevalence of mammary neoplasia to humans, a substantial disparity is apparent. Mammary neoplasia is the second most common cancer in adult female humans, with a lifetime risk of 1:8 in the United States. The reason for the disparity between humans and chimpanzees, as closely related species, is unknown. The true prevalence in chimpanzees may be higher than currently noted, because routine examination of mammary tissue in chimpanzees is generally less complete than for other tissues postmortem, and antemortem assessment is generally limited to mammary palpation. This study was performed on intact, bilateral mammary glands harvested at postmortem examination of adult female chimpanzees (n = 7) from six institutions. With mammography, complete histopathologic sectioning, and genetic evaluation, the risk of mammary neoplasia was evaluated more thoroughly than during a typical postmortem exam in zoo populations during 2017–2019. No chimpanzees in the study were diagnosed with mammary neoplasia. Overall, this study supports the previous impression that chimpanzees do not develop mammary neoplasia at a similar rate as humans, even when comparable diagnostic modalities for evaluation are used.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pan troglodytesHominidaeAnimalsHumansFemaleIncidenceAutopsyProspective Studies

Autor:innen und Institutionen

  • Lincoln Park Zoo, Chicago, IL 60614 USA, jlovstad@rwpzoo.org.
  • Lincoln Park Zoo, Chicago, IL 60614 USA.
  • North Shore University, Skokie, IL 60077 USA.
  • Zoological Pathology Program, University of Illinois College of Veterinary Medicine, Urbana, IL 61802 USA.

Zitieren

APA

Lovstad, J. N., Gamble, K., Sullivan, M., Akroush, M., & Terio, K. A. (2023). PROSPECTIVE POSTMORTEM ASSESSMENT OF THE INCIDENCE OF MAMMARY NEOPLASIA IN CHIMPANZEES (PAN TROGLODYTES). Journal of Zoo and Wildlife Medicine, 54(3), 428-434. https://doi.org/10.1638/2022-0146

Vancouver

Lovstad JN, Gamble K, Sullivan M, Akroush M, Terio KA. PROSPECTIVE POSTMORTEM ASSESSMENT OF THE INCIDENCE OF MAMMARY NEOPLASIA IN CHIMPANZEES (PAN TROGLODYTES). Journal of Zoo and Wildlife Medicine. 2023;54(3):428-434. doi:10.1638/2022-0146

BibTeX
@article{Lovstad2023,
  author = {Lovstad, Jessica N and Gamble, Kathryn and Sullivan, Megan and Akroush, Michael and Terio, Karen A},
  title = {PROSPECTIVE POSTMORTEM ASSESSMENT OF THE INCIDENCE OF MAMMARY NEOPLASIA IN CHIMPANZEES (PAN TROGLODYTES)},
  journal = {Journal of Zoo and Wildlife Medicine},
  year = {2023},
  volume = {54},
  number = {3},
  pages = {428--434},
  doi = {10.1638/2022-0146}
}
Kostenlos starten →